Targeting the AMP-activated protein kinase pathway: the active metabolites of botanical drugs represent potential strategies for treating metabolic-associated fatty liver disease

靶向AMP激活蛋白激酶通路:植物药的活性代谢产物代表了治疗代谢相关性脂肪肝疾病的潜在策略

阅读:2

Abstract

AMP-activated protein kinase (AMPK) is capable of regulating cellular energy homeostasis and mitochondrial homeostasis. The activation of AMPK can ameliorate metabolic-associated fatty liver disease (MAFLD). An increasing number of studies have demonstrated that AMPK is a crucial enzyme in the regulation of glucose and lipid metabolism in the body, and numerous botanical drugs act as AMPK activators. This activation can alleviate glucose and lipid metabolism disorders, reduce oxidative stress, and serve as a pivotal therapeutic target for metabolic diseases. MAFLD represents the liver-related manifestation of metabolic syndrome. Currently, there are well - established antidiabetic drugs in clinical practice, yet they also entail side effects. A substantial number of in vitro and in vivo experimental studies have indicated that natural traditional Chinese medicine targeting AMPK holds promising prospects in the treatment of MAFLD. In this paper, literature was retrieved through electronic databases, including the Web of Science, PubMed, Google Scholar, Springer, and CNKI (Chinese). Therefore, with AMPK as the target, this article analyzes and summarizes the process and mechanism by which botanical drugs activate AMPK to improve glucose and lipid metabolism disorders and mitochondrial homeostasis disorders, aiming to offer a broader perspective for the development of botanical drugs for MAFLD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。